Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jean‐Baptiste Bossard
Observed names:
Jean Baptiste Bossard,
Jean-Baptiste Bossard
Institution:
Centre Hospitalier de Lens
Observed institutions:
Université Toulouse III - Paul Sabatier,
Université de Lille,
Centre Hospitalier Universitaire de Lille,
Centre Hospitalier de Lens,
Evaluation des technologies de santé et des pratiques médicales,
Université de Toulouse
show all 6
ORCID:
0000-0003-0358-2547
Observed ORCID:
0000-0003-0358-2547
OpenAlex ID:
A5006567061
Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database
2016
·
Jean-Baptiste Bossard
, Camille Ponté
, et al.
·
Clinical Drug Investigation
·
46
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL)
2021
·
Loïc Renaud
, Jean Baptiste Bossard
, et al.
·
European Journal Of Haematology
·
35
Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population
2019
·
Zoe Van de Wyngaert
, Benjamin Carpentier
, et al.
·
British Journal of Haematology
·
30
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study
2020
·
Jean‐Baptiste Bossard
, Jean‐Baptiste Beuscart
, et al.
·
American Journal of Hematology
·
26
PDF
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohort
2019
·
Zoé Van de Wyngaert
, Céline Berthon
, et al.
·
International Journal of Antimicrobial Agents
·
25
PDF
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma
2022
·
Adrien Daniel
, David Ghez
, et al.
·
European Journal Of Haematology
·
8
PDF
Treatment with Temozolomide and Ibrutinib in Recurrent/Refractory Primary (PCNSL) and Secondary CNS Lymphoma (SCNSL)
2020
·
Loïc Renaud
, Jean-Baptiste Bossard
, et al.
·
Blood
·
8
Large B-cell lymphoma: The LYSA pragmatic guidelines
2025
·
Pierre Sesques
, Guillaume Manson
, et al.
·
European Journal of Cancer
·
7
PDF
Efficacy and Safety of Daratumumab in a Frail Real-Life Relapsed or Refractory Systemic Light-Chain Amyloidosis Population (AL): Report on 15 Cases from the North of France
2018
·
Zoe Van De Wyngaert
, Benjamin Carpentier
, et al.
·
Blood
·
5
Safety and efficacy of CD3xCD20 bispecific antibody for the treatment of primary and secondary central nervous system lymphoma patients: A multicentric retrospective study
2025
·
Adrien Gilbert
, Inès Boussen
, et al.
·
Blood
·
4
PDF
Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group
2019
·
Morgane Nudel
, Fanny Baran‐Marszak
, et al.
·
British Journal of Haematology
·
3
Clinical and histological study of follicular helper T-cell lymphomas with indolent evolution
2023
·
Ondine Messéant
, Fanny Drieux
, et al.
·
European Journal of Cancer
·
1
PDF
Blastoid variant mantle cell lymphoma with aberrant expression of CD10
2023
·
Benjamin Podvin
, Jean-Baptiste Bossard
, et al.
·
Annales de biologie clinique
Show more works
View as search
Works count:
13
Citation count:
198
H-index:
7
I10-index:
5
Year
Topic
Type
